Evidence map›Paper›PMID 31655107›Full record

ReviewBiochimica et biophysica acta. Molecular basis of disease2020

Cellular models of Batten disease.

Christopher J Minnis, Christopher D Thornton, Lorna M FitzPatrick, Tristan R McKay

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta. Molecular basis of disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).Frontiers in cell and developmental biology · 2022
    Review
  4. Review
  5. Altered protein secretion in Batten disease.Disease models & mechanisms · 2021
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christopher J MinnisMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, UK; Dept. Comparative Biomedical Sciences, Royal Veterinary College, Royal College Street, London NW1 0TU, UK. Electronic address: christopher.minnis.15@ucl.ac.uk.
Christopher D ThorntonCentre for Bioscience, Manchester Metropolitan University, Manchester M1 5GD, UK.
Lorna M FitzPatrickCentre for Bioscience, Manchester Metropolitan University, Manchester M1 5GD, UK.
Tristan R McKayCentre for Bioscience, Manchester Metropolitan University, Manchester M1 5GD, UK.

Funding

Biotechnology and Biological Sciences Research Council BB/M009513/1Medical Research Council MC U12266B.
6 · The paper itself

Abstract

The Neuronal Ceroid Lipofuscinoses (NCL), otherwise known as Batten disease, are a group of neurodegenerative diseases caused by mutations in 13 known genes. All except one NCL is autosomal recessive in inheritance, with similar aetiology and characterised by the accumulation of autofluorescent storage material in the lysosomes of cells. Age of onset and the rate of progression vary between the NCLs. They are collectively one of the most common lysosomal storage diseases, but the enigma remains of how genetically distinct diseases result in such remarkably similar pathogenesis. Much has been learnt from cellular studies about the function of the proteins encoded by the affected genes. Such research has utilised primitive unicellular models such as yeast and amoeba containing gene orthologues, cells derived from naturally occurring (sheep) and genetically engineered (mouse) animal models or patient-derived cells. Most recently, patient-derived induced pluripotent stem cell (iPSC) lines have been differentiated into neural cell-types to study molecular pathogenesis in the cells most profoundly affected by disease. Here, we review how cell models have informed much of the biochemical understanding of the NCLs and how more complex models are being used to further this understanding and potentially act as platforms for therapeutic efficacy studies in the future.

Indexed as

Models, BiologicalAnimalsDisease Models, AnimalHumansLysosomesNeuronal Ceroid-LipofuscinosesBatten diseaseCellular modelsCeroidNCLNeurodegenerationYeast

Identifiers

PMID31655107
PMCPMC7338907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.